Showing 5 of 25 recruiting trials for “mixed-phenotype-acute-leukemia”
Enasidenib and Azacitidine in Treating Patients With Recurrent or Refractory Acute Myeloid Leukemia and IDH2 Gene Mutation
Familial Investigations of Childhood Cancer Predisposition
👨⚕️ Kim E. Nichols, MD, St. Jude Children's Research Hospital📍 1 site📅 Started Apr 2017View details ↗
Personalized NK Cell Therapy in CBT
Cladribine, Idarubicin, Cytarabine, and Venetoclax in Treating Patients With Acute Myeloid Leukemia, High-Risk Myelodysplastic Syndrome, or Blastic Phase Chronic Myeloid Leukemia
RecruitingNCT01890486 ↗
The Prospective Collection, Storage and Reporting of Data on Patients Undergoing Hematopoietic Stem Cell Transplantation Utilizing a Standard Preparative Regimen
👨⚕️ Dianna Howard, MD, Wake Forest University Health Sciences📍 1 site📅 Started May 2001View details ↗
← PreviousPage 2 of 2
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →